EUVIMEDEUVIMED entdecken
Crossref

The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities

Eyal Elron iD, Idit Maya, Noa Shefer-Averbuch, Sarit Kahana, Reut Matar, Kochav Klein, Ifat Agmon-Fishman, Merav Gurevitch, Lina Basel-Salmon, Michal Levy

American Journal of Perinatology · 01.12.2024 · 41 (16) · 2232-2242

DOI: 10.1055/s-0044-1786514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.12.2024. Verfasst von Eyal Elron und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Schneider Children's Medical Center, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Pregnancy Trimester, Third, Amniocentesis, Microarray Analysis, DNA Copy Number Variations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to determine the diagnostic yield of chromosomal microarray analysis (CMA) performed in cases of fetal abnormalities detected during the third trimester of pregnancy. Study Design A retrospective review of medical records was conducted for women who underwent amniocentesis at or beyond 28 weeks of gestation between January 2017 and February 2023. CMA results of pregnancies with abnormal sonographic findings not detected before 28 weeks were included.

Results

A total of 482 fetuses met the inclusion criteria. The average maternal age was 31.3 years, and the average gestational age at amniocentesis was 32.3 weeks. The overall diagnostic yield of CMA was 6.2% (30 clinically significant copy number variations [CNVs]). The yield was 16.4% in cases with two or more fetal malformations, while cases with a single anomaly revealed a diagnostic yield of 7.3%. Cases presenting isolated polyhydramnios or isolated fetal growth restriction had a lower yield of 9.3 and 5.4%, respectively. Of the 30 clinically significant cases, 19 (or 63.4%) exhibited recurrent CNVs. The remaining 11 cases (or 36.6%) presented unique CNVs. The theoretical yield of Noninvasive Prenatal Testing (NIPT) in our cohort is 2% for aneuploidy, which implies that it could potentially miss up to 70% of the significant findings that could be identified by CMA. In 80% of the fetuses (or 24 out of 30) with clinically significant CNVs, the structural abnormalities detected on fetal ultrasound examinations corresponded with the CMA results.

Conclusion

The 6.2% detection rate of significant CNVs in late-onset fetal anomalies confirms the value of CMA in third-trimester amniocentesis. The findings underscore the necessity of CMA for detecting CNVs potentially overlooked by NIPT and emphasize the importance of thorough genetic counseling. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Trimester, ThirdAmniocentesisMicroarray AnalysisDNA Copy Number VariationsHumansFemalePregnancyRetrospective StudiesAdultChromosome AberrationsGestational AgePrenatal DiagnosisAneuploidyUltrasonography, PrenatalNoninvasive Prenatal TestingCongenital Abnormalities

Autor:innen und Institutionen

  • Department of Neonatology, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Pediatric Genetics Unit, Schneider Children's Medical Center, Petah Tikva, Israel.
  • The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva, Israel.
  • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, The Raphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Campus, Petah Tikva, Isr…
  • Felsenstein Medical Research Center, Petach Tikva, Israel.

ORCID-Profile: Eyal Elron

Zitieren

APA

Elron, E., Maya, I., Shefer-Averbuch, N., Kahana, S., Matar, R., Klein, K., Agmon-Fishman, I., Gurevitch, M., Basel-Salmon, L., & Levy, M. (2024). The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities. American Journal of Perinatology, 41(16), 2232-2242. https://doi.org/10.1055/s-0044-1786514

Vancouver

Elron E, Maya I, Shefer-Averbuch N, Kahana S, Matar R, Klein K, et al. The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities. American Journal of Perinatology. 2024;41(16):2232-2242. doi:10.1055/s-0044-1786514

BibTeX
@article{Elron2024,
  author = {Elron, Eyal and Maya, Idit and Shefer-Averbuch, Noa and Kahana, Sarit and Matar, Reut and Klein, Kochav and Agmon-Fishman, Ifat and Gurevitch, Merav and Basel-Salmon, Lina and Levy, Michal},
  title = {The Diagnostic Yield of Chromosomal Microarray Analysis in Third-Trimester Fetal Abnormalities},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {16},
  pages = {2232--2242},
  doi = {10.1055/s-0044-1786514}
}
Kostenlos starten →